Adrian Rawcliffe

Biography

Adrian Rawcliffe serves as the Chief Financial Officer at Adaptimmune Therapeutics plc and leads financial strategy, management and operations functions including financial compliance and risk management, global IT, HR and facilities. He has 17 years of experience within the pharmaceutical industry and previously served as Senior Vice President, Finance of GSK’s North American Pharmaceuticals business. Mr. Rawcliffe joined GSK in 1998 and his other senior roles at the company included Senior Vice President Worldwide Business Development and R&D Finance, where he was responsible for all business development and finance activities for GSK’s Pharmaceuticals R&D business and Managing Partner and President of SR One Ltd, GSK’s venture capital business. Mr. Rawcliffe qualified as a chartered accountant with PricewaterhouseCoopers and holds a B.Sc. degree in Natural Sciences from the University of Durham, U.K.

Research Interest

Pharmaceutical Sciences